Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia.

[1]  H. Honda,et al.  Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes , 2003, Melanoma research.

[2]  J. Zee,et al.  Heating the patient: a promising approach? , 2002 .

[3]  P. Moroz,et al.  Magnetically mediated hyperthermia: current status and future directions , 2002, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[4]  H. Honda,et al.  Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia , 2001, Cancer Immunology, Immunotherapy.

[5]  Jun Yoshida,et al.  Targeting Hyperthermia for Renal Cell Carcinoma Using Human MN Antigenspecific Magnetoliposomes , 2001, Japanese journal of cancer research : Gann.

[6]  Takeshi Kobayashi,et al.  Interstitial Hyperthermia Using Magnetite Cationic Liposomes Inhibit to Tumor Growth of VX-7 Transplanted Tumor in Rabbit Tongue , 2001 .

[7]  P. Dennis,et al.  Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. , 2001, Cancer research.

[8]  S. Kasaoka,et al.  Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats. , 2000, International journal of oncology.

[9]  S. R. Datta,et al.  Cellular survival: a play in three Akts. , 1999, Genes & development.

[10]  M. Sliwkowski,et al.  Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers , 1999, Oncogene.

[11]  Jun Yoshida,et al.  Intracellular Hyperthermia for Cancer Using Magnetite Cationic Liposomes: Ex vivo Study , 1996, Japanese journal of cancer research : Gann.

[12]  H Honda,et al.  Development of a target-directed magnetic resonance contrast agent using monoclonal antibody-conjugated magnetic particles. , 1996, Noshuyo byori = Brain tumor pathology.

[13]  John W. Park,et al.  Development of anti-p185HER2 immunoliposomes for cancer therapy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Taupitz,et al.  Contrast‐enhanced MR imaging of liver and spleen: First experience in humans with a new superparamagnetic iron oxide , 1994, Journal of magnetic resonance imaging : JMRI.

[15]  Takeshi Kobayashi,et al.  Heat Properties of Magnetoliposomes for Local Hyperthermia , 1994 .

[16]  P. Carter,et al.  Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies , 1993, Cancer Immunology, Immunotherapy.

[17]  L. Presta,et al.  Humanization of an anti-p185HER2 antibody for human cancer therapy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Toy,et al.  A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines. , 1991, Cancer research.

[19]  C. Cordon-Cardo,et al.  Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. , 1990, Oncogene.

[20]  A. Ullrich,et al.  p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor , 1989, Molecular and cellular biology.

[21]  R Weissleder,et al.  Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. , 1988, Radiology.

[22]  C. Owen,et al.  Magnetic labeling and cell sorting. , 1984, Journal of immunological methods.

[23]  E. Kano,et al.  Effects of Hyperthermia at 50°C on V-79 Cells in vitro , 1982 .

[24]  F. Valeriote,et al.  Synergistic interaction of anticancer agents: a cellular perspective. , 1975, Cancer chemotherapy reports.

[25]  F. Hamdy,et al.  The ne w e ngl and j our na l of medicine , 2023 .

[26]  J. Baselga,et al.  The epidermal growth factor receptor as a target for therapy in breast carcinoma , 2004, Breast Cancer Research and Treatment.

[27]  Jun Yoshida,et al.  Preparation of Tumor-Specific Magnetoliposomes and Their Application for Hyperthermia , 2001 .